학술논문
A Phase 1/2 Trial of a Combination of Paclitaxel and Trastuzumab With Daily Irradiation or Paclitaxel Alone With Daily Irradiation After Transurethral Surgery for Noncystectomy Candidates With Muscle-Invasive Bladder Cancer (Trial NRG Oncology RTOG 0524)
Document Type
Article
Author
Source
In International Journal of Radiation Oncology, Biology, Physics 1 April 2017 97(5):995-1001
Subject
Language
ISSN
0360-3016